The global vascular access device market size was valued at US$ 3,744.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2020 to 2028. The vascular access device is defined as a device that allows easy administration of fluids, blood products, and medications into veins via peripheral or central vessels to permit monitoring of haemodynamic function, dialysis, and collecting of blood specimens. It contains intravascular devices inserted into peripheral veins, peripheral intravenous cannula (PIVC), peripheral arterial devices, central venous catheters, and peripherally inserted central catheters (PICC lines).
The industry is expected to be driven by the growing number of chronic diseases along with the rising geriatric population. The speedily growing healthcare industry as well as increasing per capita expenditure in developing countries is anticipated to boost the demand of this segment over the forecast period. The increasing Number of Chemotherapy Procedures and technological advancements are the factors expected to have a positive impact on the market growth in upcoming years.
The Global Vascular Access Device market is categorized on the basis of product, end-user, and region. On the basis of product type, the market is segmented into Portal Access Needles, Implantable Ports, Sheath Introducer, IV Safety Catheters, Central Venous Catheter, Peripherally Inserted Central Catheter, and Catheter Stabilization. On the basis of end-user, the market is segmented into General Anesthesia, Regional Anesthesia, Oncology, Pain Management, Adult Critical Care, Neo Critical Care, and Home and Alternate Care. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
The key players of this market include Teleflex Incorporated, Smiths Medical, Inc., B Braun Melsungen AG, COOK Medical, Angiodynamics (Navilyst Medical, Inc), Districlass medical, Guangdong Baihe Medical Technology, HEKA Srl, F.B. Medical, I beg – Instituto de Bioengenharia Erasto Gaertner, PakuMed medical products, Perouse Medical, Terumo Corporation, Nipro Medical Corporation, Merit Medical Systems, Inc., Vygon S.A., Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd., and Prodimed.
Global Vascular Access Device Market Segmentation
Global Vascular Access Device Market Based on Product
Global Vascular Access Device Market Based on End-user
Global Vascular Access Device Market Based on Region
Europe Vascular Access Device Market by Country
North America Vascular Access Device Market by Country
Asia Pacific Vascular Access Device Market by Country
Latin America Vascular Access Device Market by Country
Middle East & Africa Vascular Access Device Market by Country
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.